Olopatadine - NDSRI's

NDSRI of alpha hydroxy Olopatadine (mixture of isomers)

  • CAT NUMBER DCTI-C-3878
  • CAS NUMBER NA
  • MOLECULAR FORMULA C20H20N2O5
  • MOLECULAR WEIGHT 368.39

NDSRI of Olopatadine E- isomer(mixture of isomers)

  • CAT NUMBER DCTI-C-3924
  • CAS NUMBER NA
  • MOLECULAR FORMULA C20H20N2O5
  • MOLECULAR WEIGHT 368.39
References
FAQ's

Frequently Asked Questions

Impurities in Olopatadine arise from the starting materials, reagents, or by-products. They can also form during storage or due to degradation.

Methods such as LC-MS and HPLC help detect related substances in Olopatadine.

Impurities in Olopatadine pose risks to patients with toxicity, decreased effectiveness, or adverse reactions to the drug.

Many methods reduce or eliminate Olopatadine impurities, like optimization of the synthetic process, good quality raw materials and reagents, controlling reaction conditions, and minimizing exposure to environmental factors. In addition, effective purification techniques and analytical methods, such as HPLC or LC-MS, help detect impurities and ensure the drug meets regulatory standards.

Olopatadine impurities are stored at a controlled room temperature between 2-8 ⁰C or as indicated on the Certificate of Analysis (CoA).

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart